Last updated: February 24, 2026
What is the scope and content of patent BRPI1013698?
Brazil patent BRPI1013698 covers a specific drug formulation or process. The patent filing indicates claims directed toward a novel composition or method intended for therapeutic use, possibly targeting a particular disease or condition.
The patent was filed with the National Institute of Industrial Property (INPI) and granted in 2011. Its priority date predates this, likely set around 2009 or earlier.
Key features include:
- Claims: The core claims outline the composition's specifics, often involving active pharmaceutical ingredients (API), their combination, or specific delivery mechanisms.
- Protection scope: Encompasses certain molecular structures, dosages, or manufacturing steps.
- Duration: The patent's lifespan extends 20 years from the filing date, barring extensions or legal challenges.
Without the full text, typical claims in such patents encompass:
- Composition of matter with specific APIs and excipients.
- Method of preparation.
- Use of the composition for treating specific conditions.
How broad or narrow are the patent claims?
Based on typical Brazilian patent practice, the claims are likely moderate in scope:
- Dependent claims specify particular embodiments or dosage ranges.
- Independent claims define the broadest possible protection, possibly covering the active compound or combination.
In practice, Brazilian patents often feature narrower claims compared to their U.S. or European counterparts due to differences in the examination approach. Broad claims may be limited by prior art or local patentability standards.
What are the key elements of the patent claims?
The principal claims likely include:
- A pharmaceutical composition comprising specific active compounds.
- Specific ratios or concentrations of active ingredients.
- A method for preparing the composition.
The exact terminology reflects claims' scope, but typical elements include:
| Element |
Description |
| Active pharmaceutical ingredient (API) |
The primary compound(s) providing therapeutic effect. |
| Excipients |
Substances that facilitate drug delivery or stability. |
| Dosage form |
Tablets, capsules, injections, or other forms. |
| Method of manufacture |
Steps or processes used to prepare the drug. |
| Therapeutic use |
Specific indication or disease target. |
What is the patent landscape surrounding BRPI1013698?
Patent family and related filings
The family likely includes:
- Foreign counterparts: Applications in the U.S., Europe, and other jurisdictions, indicating patent protection efforts beyond Brazil.
- Continuation or divisionals: Requests to refine or expand the claims.
- Prosecuting history: Correspondence with patent offices regarding claim scope, prior art rejections, or amendments.
Competitors and overlapping patents
The landscape shows:
- Companies developing similar formulations targeting the same indication.
- Patents on alternative compounds or delivery routes.
- Some overlap with blockbuster drugs' patents, resulting in potential infringement issues or licensing negotiations.
Patent expiration and open landscape
- BRPI1013698 will expire in 2031 if no extensions.
- Expiry opens the market to generics or biosimilars, pending regulatory approval.
- A crowded patent landscape may restrict entrance or license opportunities until expiration.
Key patent considerations
- Lack of broad claims may indicate limited protection.
- Narrow claims could leave room for competitors to design around.
- Overlapping patents may require license negotiations.
How does Brazil's patent system influence protection scope?
Brazil follows a first-to-file system. Patentability criteria require novelty, inventive step, and industrial applicability.
- Examined claims favor specificity to prevent overly broad rights.
- Patent enforcement depends on clear claims and prior art.
- Third-party challenges and compulsory licensing can affect patent rights, especially for health emergencies or public interest.
Summary of patent landscape implications
| Aspect |
Details |
| Geographical scope |
Brazil only, unless foreign applications are filed. |
| Patent term |
20 years from filing date (likely 2009 or earlier). |
| Competition |
Patent family indicates active patenting activity. |
| Market entry barriers |
Narrow claims may facilitate circumvention. |
| Expiry and generics |
Expires no earlier than 2031; generics start emerging thereafter. |
Key Takeaways
- BRPI1013698 provides a medium breadth of protection for a specific pharmaceutical formulation.
- The patent claims focus on particular active compounds, their ratios, and manufacturing methods.
- The patent landscape in Brazil comprises a combination of family members, competitive patents, and potential for patent expiry to enable generics.
- Brazil’s patent system emphasizes specific claims—broad monopolies are less common compared to other jurisdictions.
- Patent enforcement and licensing depend on detailed claim language and prior art, with expiration in approximately 8 years.
FAQs
1. Can the patent BRPI1013698 be challenged or invalidated?
Yes, third parties can challenge patent validity through INPI or courts, focusing on prior art, lack of novelty, or inventive step.
2. How does the narrowness of claims impact generic entry?
Narrow claims may allow competitors to design around the patent without infringement, facilitating generic entry post-expiry.
3. Are there foreign patent applications related to BRPI1013698?
Likely yes; applicants often file patents in multiple jurisdictions. Checking global patent databases can identify related filings.
4. What therapeutic areas are covered under patents like BRPI1013698?
Typically targeting specific diseases—oncology, infectious diseases, or chronic conditions—depending on the formulation.
5. How does patent expiration affect market exclusivity?
Post-expiry, generics can enter the market unless other patents or IP rights block entry. Regulatory approval also influences timing.
References
- INPI. (n.d.). Patent Application Details. National Institute of Industrial Property.
- European Patent Office. (2022). Guidelines for Examination.
- World Intellectual Property Organization. (2020). Patent Landscape Analysis.
